Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony W Fox

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Pharmaceutical Medicine|December 24, 2024
Author's Reply to Pongpirul: "The Pharmaceutical Year that was, 2024"Anthony W Fox
Journal of Clinical Pharmacology|November 5, 2002
5HT1B/1D agonistsAnthony W Fox
Pharmaceutical Medicine|October 12, 2024
The Pharmaceutical Year that was, 2024Anthony W Fox
Headache|February 6, 2004
Onset of effect of 5-HT1B/1D agonists: a model with pharmacokinetic validationAnthony W Fox
Pharmaceutical Medicine|October 1, 2025
The Pharmaceutical Year That Was, 2025Anthony W Fox
Headache|August 20, 2005
Clinical trial ethicsAnthony W Fox
Headache|November 21, 2009
Subcutaneous sumatriptan pharmacokinetics: delimiting the monoamine oxidase inhibitor effectAnthony W Fox
Headache|August 30, 2003
"Safety" testing and herbal remediesAnthony W Fox
Headache|July 17, 2003
Disease is not a basis for subspeciationAnthony W Fox
Headache|September 27, 2008
Disease modification in migraine: study design and sample size implicationsAnthony W Fox
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Pharmaceutical Medicine|December 24, 2024
Author's Reply to Pongpirul: "The Pharmaceutical Year that was, 2024"Anthony W Fox
Journal of Clinical Pharmacology|November 5, 2002
5HT1B/1D agonistsAnthony W Fox
Pharmaceutical Medicine|October 12, 2024
The Pharmaceutical Year that was, 2024Anthony W Fox
Headache|February 6, 2004
Onset of effect of 5-HT1B/1D agonists: a model with pharmacokinetic validationAnthony W Fox
Pharmaceutical Medicine|October 1, 2025
The Pharmaceutical Year That Was, 2025Anthony W Fox
Headache|August 20, 2005
Clinical trial ethicsAnthony W Fox
Headache|November 21, 2009
Subcutaneous sumatriptan pharmacokinetics: delimiting the monoamine oxidase inhibitor effectAnthony W Fox
Headache|August 30, 2003
"Safety" testing and herbal remediesAnthony W Fox
Headache|July 17, 2003
Disease is not a basis for subspeciationAnthony W Fox
Headache|September 27, 2008
Disease modification in migraine: study design and sample size implicationsAnthony W Fox
Pageof 5